NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|45550531|ref|NP_647762|]
View 

sphingosine kinase 2 [Drosophila melanogaster]

Protein Classification

sphingosine kinase( domain architecture ID 1002441)

sphingosine kinase catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions; also acts on D-erythro-sphingosine and to a lesser extent sphinganine, but not other lipids, such as D,L-threo-dihydrosphingosine, N,N-dimethylsphingosine, diacylglycerol, ceramide, or phosphatidylinositol

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PLN02958 super family cl29912
diacylglycerol kinase/D-erythro-sphingosine kinase
213-639 4.79e-43

diacylglycerol kinase/D-erythro-sphingosine kinase


The actual alignment was detected with superfamily member PLN02958:

Pssm-ID: 215517 [Multi-domain]  Cd Length: 481  Bit Score: 161.95  E-value: 4.79e-43
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  213 RRRRVLVLLNPKSGSGDAREVFNMHVTPVLNEAEVPYDLYVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNGLL 292
Cdd:PLN02958 110 RPKRLLVFVNPFGGKKSASKIFFDVVKPLLEDADIQLTIQETKYQLHAKEVVRTMDLSKYDGIVCVSGDGILVEVVNGLL 189
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  293 QRQDWAHVLpHLALGIIPCGSGNGLARSIAHCYNEPYFSKpvlGAALTVISGRSSPMDVVRVQLQSRSLYSFLSIGWGLI 372
Cdd:PLN02958 190 EREDWKTAI-KLPIGMVPAGTGNGMAKSLLDSVGEPCSAT---NAVLAIIRGHKCSLDVATILQGETKFFSVLMLAWGLV 265
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  373 SDVDIESERIRMLGYQRFTVWTLYRLVNLRTYNGRISYLltdhevssthsatgyaaqrrmqssrscnthidmlngPAPIY 452
Cdd:PLN02958 266 ADIDIESEKYRWMGSARLDFYGLQRILCLRQYNGRISFV------------------------------------PAPGF 309
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  453 HSSAEylpqefadvislETSINQSFRSRcdswlsggsrrsfyysisesiyhsladesefaglaAASLENRQQNY-GPASE 531
Cdd:PLN02958 310 EAYGE------------PTSYNGESTSK-----------------------------------EESGKDKQHGYqGPDVK 342
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  532 LPDLNeplsedqgWLVEEGEFV--MMHAVYQThlGIDCHFAPKAQLNDGTIYLILIRAGISRPhLLSFLYNMSSGTHLPE 609
Cdd:PLN02958 343 LENLD--------WRTIKGPFVsvWLHNVPWG--GEDTLAAPDAKFSDGYLDLILIKDCPKLA-LLALMTKLSDGTHVKS 411
                        410       420       430
                 ....*....|....*....|....*....|....*.
gi 45550531  610 ShddHVKVLPVRAFRLEP------YDNHGIITVDGE 639
Cdd:PLN02958 412 P---YVMYLKVKAFVLEPgprtddPTKGGIIDSDGE 444
 
Name Accession Description Interval E-value
PLN02958 PLN02958
diacylglycerol kinase/D-erythro-sphingosine kinase
213-639 4.79e-43

diacylglycerol kinase/D-erythro-sphingosine kinase


Pssm-ID: 215517 [Multi-domain]  Cd Length: 481  Bit Score: 161.95  E-value: 4.79e-43
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  213 RRRRVLVLLNPKSGSGDAREVFNMHVTPVLNEAEVPYDLYVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNGLL 292
Cdd:PLN02958 110 RPKRLLVFVNPFGGKKSASKIFFDVVKPLLEDADIQLTIQETKYQLHAKEVVRTMDLSKYDGIVCVSGDGILVEVVNGLL 189
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  293 QRQDWAHVLpHLALGIIPCGSGNGLARSIAHCYNEPYFSKpvlGAALTVISGRSSPMDVVRVQLQSRSLYSFLSIGWGLI 372
Cdd:PLN02958 190 EREDWKTAI-KLPIGMVPAGTGNGMAKSLLDSVGEPCSAT---NAVLAIIRGHKCSLDVATILQGETKFFSVLMLAWGLV 265
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  373 SDVDIESERIRMLGYQRFTVWTLYRLVNLRTYNGRISYLltdhevssthsatgyaaqrrmqssrscnthidmlngPAPIY 452
Cdd:PLN02958 266 ADIDIESEKYRWMGSARLDFYGLQRILCLRQYNGRISFV------------------------------------PAPGF 309
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  453 HSSAEylpqefadvislETSINQSFRSRcdswlsggsrrsfyysisesiyhsladesefaglaAASLENRQQNY-GPASE 531
Cdd:PLN02958 310 EAYGE------------PTSYNGESTSK-----------------------------------EESGKDKQHGYqGPDVK 342
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  532 LPDLNeplsedqgWLVEEGEFV--MMHAVYQThlGIDCHFAPKAQLNDGTIYLILIRAGISRPhLLSFLYNMSSGTHLPE 609
Cdd:PLN02958 343 LENLD--------WRTIKGPFVsvWLHNVPWG--GEDTLAAPDAKFSDGYLDLILIKDCPKLA-LLALMTKLSDGTHVKS 411
                        410       420       430
                 ....*....|....*....|....*....|....*.
gi 45550531  610 ShddHVKVLPVRAFRLEP------YDNHGIITVDGE 639
Cdd:PLN02958 412 P---YVMYLKVKAFVLEPgprtddPTKGGIIDSDGE 444
DAGK_cat pfam00781
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ...
216-354 2.65e-36

Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.


Pssm-ID: 425868 [Multi-domain]  Cd Length: 125  Bit Score: 132.32  E-value: 2.65e-36
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531   216 RVLVLLNPKSGSGDAREVFNmHVTPVLNEAEVPYDLYVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNGLlqrq 295
Cdd:pfam00781   1 KLLVIVNPKSGGGKGKKLLR-KVRPLLNKAGVEVELVLTEGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGL---- 75
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 45550531   296 dwAHVLPHLALGIIPCGSGNGLARSIahcynepYFSKPVLGAALTVISGRSSPMDVVRV 354
Cdd:pfam00781  76 --AGLATRPPLGIIPLGTGNDFARAL-------GIPGDPEEALEAILKGQTRPVDVGKV 125
LCB5 COG1597
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ...
213-661 3.66e-27

Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];


Pssm-ID: 441205 [Multi-domain]  Cd Length: 295  Bit Score: 111.87  E-value: 3.66e-27
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 213 RRRRVLVLLNPKSGSGDAREVFNmHVTPVLNEAEVPYDLYVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNGLL 292
Cdd:COG1597   1 AMMRALLIVNPASGRGRAARLLE-RLVAALRAAGLEVEVLETESPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLA 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 293 QRQdwahvlphLALGIIPCGSGNGLARSIAhcynepyFSKPVLGAALTVISGRSSPMDVVRVqlqsRSLYSFLSIGWGLI 372
Cdd:COG1597  80 GTG--------PPLGILPLGTGNDFARALG-------IPLDPEAALEALLTGRTRRIDLGRV----NGRYFLNVAGIGFD 140
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 373 SDV--DIESERIRMLGYQRFTVWTLYRLVNLRTYNGRISYlltdhevssthsatgyaaqrrmqssrscnthidmlngpap 450
Cdd:COG1597 141 AEVveRANRALKRRLGKLAYVLAALRALLRYRPFRLRIEL---------------------------------------- 180
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 451 iyhssaeylpqefadvisletsinqsfrsrcdswlsggsrrsfyysisesiyhslaDESEFaglaaaslenrqqnygpas 530
Cdd:COG1597 181 --------------------------------------------------------DGEEI------------------- 185
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 531 elpdlneplsEDQGWLVeegeFVMMHAVYQTHLGIdchfAPKAQLNDGTIYLILIRAgISRPHLLSFLYNMSSGTHLpes 610
Cdd:COG1597 186 ----------EGEALLV----AVGNGPYYGGGLRL----APDASLDDGLLDVVVVRP-LSRLRLLRLLPRLLRGRHL--- 243
                       410       420       430       440       450
                ....*....|....*....|....*....|....*....|....*....|..
gi 45550531 611 HDDHVKVLPVRAFRLEPyDNHGIITVDGERVEFG-PLQAEVLPGIARVMVPK 661
Cdd:COG1597 244 RHPGVRYFRAREVEIES-DRPLPVQLDGEPLGLAtPLEFEVLPGALRVLVPA 294
DAGKc smart00046
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ...
218-350 4.79e-17

Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.


Pssm-ID: 214487 [Multi-domain]  Cd Length: 124  Bit Score: 77.72  E-value: 4.79e-17
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531    218 LVLLNPKSGSGDAREvFNMHVTPVLNEAEVpYDLYVTKHsNFAIEFLstRCLDAWCCVVAVGGDGLFHEIVNGLLQRQDw 297
Cdd:smart00046   1 LVFVNPKSGGGKGEK-LLRKFRLLLNPRQV-FDLTKKGP-AVALVIF--RDVPDFNRVLVCGGDGTVGWVLNALDKREL- 74
                           90       100       110       120       130
                   ....*....|....*....|....*....|....*....|....*....|...
gi 45550531    298 ahVLPHLALGIIPCGSGNGLARSIAHCYNEPYFskPVLGAALTVISGRSSPMD 350
Cdd:smart00046  75 --PLPEPPVAVLPLGTGNDLARSLGWGGGYDGE--KLLKTLRDALESDTVKLD 123
TIGR00147 TIGR00147
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ...
215-410 1.32e-12

lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]


Pssm-ID: 161732 [Multi-domain]  Cd Length: 293  Bit Score: 68.68  E-value: 1.32e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531   215 RRVLVLLNPKSGsgdaREVFNMH---VTPVLNEAEVPYDLYVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNGL 291
Cdd:TIGR00147   2 AEAPAILNPTAG----KSNDNKPlreVIMLLREEGMEIHVRVTWEKGDAARYVEEARKFGVDTVIAGGGDGTINEVVNAL 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531   292 LQRQDwahvLPhlALGIIPCGSGNGLARSiahcynepyFSKP--VLGAALTVISGRSSPMDVVRVQLQsrslYSFLSI-G 368
Cdd:TIGR00147  78 IQLDD----IP--ALGILPLGTANDFARS---------LGIPedLDKAAKLVIAGDARAIDMGQVNKQ----YCFINMaG 138
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....
gi 45550531   369 WGLISDV--DIESERIRMLGYQRFTVWTLYRLVNLRTYNGRISY 410
Cdd:TIGR00147 139 GGFGTEIttETPEKLKAALGSLSYILSGLMRMDTLQPFRCEIRG 182
 
Name Accession Description Interval E-value
PLN02958 PLN02958
diacylglycerol kinase/D-erythro-sphingosine kinase
213-639 4.79e-43

diacylglycerol kinase/D-erythro-sphingosine kinase


Pssm-ID: 215517 [Multi-domain]  Cd Length: 481  Bit Score: 161.95  E-value: 4.79e-43
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  213 RRRRVLVLLNPKSGSGDAREVFNMHVTPVLNEAEVPYDLYVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNGLL 292
Cdd:PLN02958 110 RPKRLLVFVNPFGGKKSASKIFFDVVKPLLEDADIQLTIQETKYQLHAKEVVRTMDLSKYDGIVCVSGDGILVEVVNGLL 189
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  293 QRQDWAHVLpHLALGIIPCGSGNGLARSIAHCYNEPYFSKpvlGAALTVISGRSSPMDVVRVQLQSRSLYSFLSIGWGLI 372
Cdd:PLN02958 190 EREDWKTAI-KLPIGMVPAGTGNGMAKSLLDSVGEPCSAT---NAVLAIIRGHKCSLDVATILQGETKFFSVLMLAWGLV 265
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  373 SDVDIESERIRMLGYQRFTVWTLYRLVNLRTYNGRISYLltdhevssthsatgyaaqrrmqssrscnthidmlngPAPIY 452
Cdd:PLN02958 266 ADIDIESEKYRWMGSARLDFYGLQRILCLRQYNGRISFV------------------------------------PAPGF 309
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  453 HSSAEylpqefadvislETSINQSFRSRcdswlsggsrrsfyysisesiyhsladesefaglaAASLENRQQNY-GPASE 531
Cdd:PLN02958 310 EAYGE------------PTSYNGESTSK-----------------------------------EESGKDKQHGYqGPDVK 342
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  532 LPDLNeplsedqgWLVEEGEFV--MMHAVYQThlGIDCHFAPKAQLNDGTIYLILIRAGISRPhLLSFLYNMSSGTHLPE 609
Cdd:PLN02958 343 LENLD--------WRTIKGPFVsvWLHNVPWG--GEDTLAAPDAKFSDGYLDLILIKDCPKLA-LLALMTKLSDGTHVKS 411
                        410       420       430
                 ....*....|....*....|....*....|....*.
gi 45550531  610 ShddHVKVLPVRAFRLEP------YDNHGIITVDGE 639
Cdd:PLN02958 412 P---YVMYLKVKAFVLEPgprtddPTKGGIIDSDGE 444
DAGK_cat pfam00781
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ...
216-354 2.65e-36

Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.


Pssm-ID: 425868 [Multi-domain]  Cd Length: 125  Bit Score: 132.32  E-value: 2.65e-36
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531   216 RVLVLLNPKSGSGDAREVFNmHVTPVLNEAEVPYDLYVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNGLlqrq 295
Cdd:pfam00781   1 KLLVIVNPKSGGGKGKKLLR-KVRPLLNKAGVEVELVLTEGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGL---- 75
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 45550531   296 dwAHVLPHLALGIIPCGSGNGLARSIahcynepYFSKPVLGAALTVISGRSSPMDVVRV 354
Cdd:pfam00781  76 --AGLATRPPLGIIPLGTGNDFARAL-------GIPGDPEEALEAILKGQTRPVDVGKV 125
LCB5 COG1597
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ...
213-661 3.66e-27

Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];


Pssm-ID: 441205 [Multi-domain]  Cd Length: 295  Bit Score: 111.87  E-value: 3.66e-27
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 213 RRRRVLVLLNPKSGSGDAREVFNmHVTPVLNEAEVPYDLYVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNGLL 292
Cdd:COG1597   1 AMMRALLIVNPASGRGRAARLLE-RLVAALRAAGLEVEVLETESPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLA 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 293 QRQdwahvlphLALGIIPCGSGNGLARSIAhcynepyFSKPVLGAALTVISGRSSPMDVVRVqlqsRSLYSFLSIGWGLI 372
Cdd:COG1597  80 GTG--------PPLGILPLGTGNDFARALG-------IPLDPEAALEALLTGRTRRIDLGRV----NGRYFLNVAGIGFD 140
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 373 SDV--DIESERIRMLGYQRFTVWTLYRLVNLRTYNGRISYlltdhevssthsatgyaaqrrmqssrscnthidmlngpap 450
Cdd:COG1597 141 AEVveRANRALKRRLGKLAYVLAALRALLRYRPFRLRIEL---------------------------------------- 180
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 451 iyhssaeylpqefadvisletsinqsfrsrcdswlsggsrrsfyysisesiyhslaDESEFaglaaaslenrqqnygpas 530
Cdd:COG1597 181 --------------------------------------------------------DGEEI------------------- 185
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531 531 elpdlneplsEDQGWLVeegeFVMMHAVYQTHLGIdchfAPKAQLNDGTIYLILIRAgISRPHLLSFLYNMSSGTHLpes 610
Cdd:COG1597 186 ----------EGEALLV----AVGNGPYYGGGLRL----APDASLDDGLLDVVVVRP-LSRLRLLRLLPRLLRGRHL--- 243
                       410       420       430       440       450
                ....*....|....*....|....*....|....*....|....*....|..
gi 45550531 611 HDDHVKVLPVRAFRLEPyDNHGIITVDGERVEFG-PLQAEVLPGIARVMVPK 661
Cdd:COG1597 244 RHPGVRYFRAREVEIES-DRPLPVQLDGEPLGLAtPLEFEVLPGALRVLVPA 294
DAGKc smart00046
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ...
218-350 4.79e-17

Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.


Pssm-ID: 214487 [Multi-domain]  Cd Length: 124  Bit Score: 77.72  E-value: 4.79e-17
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531    218 LVLLNPKSGSGDAREvFNMHVTPVLNEAEVpYDLYVTKHsNFAIEFLstRCLDAWCCVVAVGGDGLFHEIVNGLLQRQDw 297
Cdd:smart00046   1 LVFVNPKSGGGKGEK-LLRKFRLLLNPRQV-FDLTKKGP-AVALVIF--RDVPDFNRVLVCGGDGTVGWVLNALDKREL- 74
                           90       100       110       120       130
                   ....*....|....*....|....*....|....*....|....*....|...
gi 45550531    298 ahVLPHLALGIIPCGSGNGLARSIAHCYNEPYFskPVLGAALTVISGRSSPMD 350
Cdd:smart00046  75 --PLPEPPVAVLPLGTGNDLARSLGWGGGYDGE--KLLKTLRDALESDTVKLD 123
PLN02204 PLN02204
diacylglycerol kinase
212-443 1.55e-13

diacylglycerol kinase


Pssm-ID: 215126 [Multi-domain]  Cd Length: 601  Bit Score: 73.77  E-value: 1.55e-13
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  212 ERRRRVLVLLNPKSGSGDAREVFNMhVTPVLNEAEVPYDLYVTKHSNFAIEFLST---RCLDAWCCVVAVGGDGLFHEIV 288
Cdd:PLN02204 157 GRPKNLLVFVHPLSGKGSGSRTWET-VSPIFIRAKVKTKVIVTERAGHAFDVMASisnKELKSYDGVIAVGGDGFFNEIL 235
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  289 NGLL-----------------QRQDWAHVLPH------------------------------------------------ 303
Cdd:PLN02204 236 NGYLlsrlkvpyppspsdsvhSVQSRGSSSVHepnetvhecdnedhspllsdsvqevmnfrtengscegdqdsdfpfpne 315
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  304 -LALGIIPCGSGNGLARSIAHCYNepyfskPVLgAALTVISGRSSPMD---VVRVQLQSRS------LYSFLSIGWGLIS 373
Cdd:PLN02204 316 rFRFGIIPAGSTDAIVMCTTGERD------PVT-SALHIILGRRVCLDiaqVVRWKTTSTSeiepyvRYAASFAGYGFYG 388
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  374 DVDIESERIRMLGYQRFTVWTLYRLVNLRTYNGRISYLltdhEVSSTHSATGYAAQRRMQSSRS-----------CNTHI 442
Cdd:PLN02204 389 DVISESEKYRWMGPKRYDYAGTKVFLKHRSYEAEVAYL----ETESEKSKASSEARKRTGPKKSekivcrtncsvCNTKV 464

                 .
gi 45550531  443 D 443
Cdd:PLN02204 465 S 465
TIGR00147 TIGR00147
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ...
215-410 1.32e-12

lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]


Pssm-ID: 161732 [Multi-domain]  Cd Length: 293  Bit Score: 68.68  E-value: 1.32e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531   215 RRVLVLLNPKSGsgdaREVFNMH---VTPVLNEAEVPYDLYVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNGL 291
Cdd:TIGR00147   2 AEAPAILNPTAG----KSNDNKPlreVIMLLREEGMEIHVRVTWEKGDAARYVEEARKFGVDTVIAGGGDGTINEVVNAL 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531   292 LQRQDwahvLPhlALGIIPCGSGNGLARSiahcynepyFSKP--VLGAALTVISGRSSPMDVVRVQLQsrslYSFLSI-G 368
Cdd:TIGR00147  78 IQLDD----IP--ALGILPLGTANDFARS---------LGIPedLDKAAKLVIAGDARAIDMGQVNKQ----YCFINMaG 138
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....
gi 45550531   369 WGLISDV--DIESERIRMLGYQRFTVWTLYRLVNLRTYNGRISY 410
Cdd:TIGR00147 139 GGFGTEIttETPEKLKAALGSLSYILSGLMRMDTLQPFRCEIRG 182
PRK13337 PRK13337
putative lipid kinase; Reviewed
214-354 9.89e-09

putative lipid kinase; Reviewed


Pssm-ID: 183982 [Multi-domain]  Cd Length: 304  Bit Score: 57.37  E-value: 9.89e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  214 RRRVLVLLNPKSGsgdaREVFNMHVTPVLNEAEVP-YDL--YVTKHSNFAIEFLSTRCLDAWCCVVAVGGDGLFHEIVNG 290
Cdd:PRK13337   1 MKRARIIYNPTSG----RELFKKNLPDVLQKLEQAgYETsaHATTGPGDATLAAERAVERKFDLVIAAGGDGTLNEVVNG 76
                         90       100       110       120       130       140
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 45550531  291 LLQrqdwahvLPHL-ALGIIPCGSGNGLARSIahcynepYFSKPVLGAALTVISGRSSPMDVVRV 354
Cdd:PRK13337  77 IAE-------KENRpKLGIIPVGTTNDFARAL-------HVPRDIEKAADVIIEGHTVPVDIGKA 127
PRK13059 PRK13059
putative lipid kinase; Reviewed
568-661 1.58e-06

putative lipid kinase; Reviewed


Pssm-ID: 183858  Cd Length: 295  Bit Score: 50.42  E-value: 1.58e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  568 HFAPKAQLNDGTIYLILIRAGiSRPHLLSFLYNMSSGTHLpeshDDHVKVLPVRAFRLEPYDNHGIIT-VDGERVEFGPL 646
Cdd:PRK13059 204 NLAYKAEVDDGLLDVIIIKAC-PIIDLIPLFIKVLKGEHL----EDVNGLIYFKTDKLEIESNEEIVTdIDGERGPDFPL 278
                         90
                 ....*....|....*
gi 45550531  647 QAEVLPGIARVMVPK 661
Cdd:PRK13059 279 NIECIKGGLKVLGIL 293
YegS_C pfam19279
YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal ...
568-659 1.89e-06

YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal domain found in the YegS protein. It is related to the beta sandwich domain of NAD kinases. The structure of YegS reveals a two-domain protein with the active site crevice found between the two domains. The C-terminal domain contains 13 beta-strands and two alpha-helices. The likely substrate for YegS is phosphatidylglycerol.


Pssm-ID: 437111  Cd Length: 158  Bit Score: 48.35  E-value: 1.89e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531   568 HFAPKAQLNDGTIYLILIRAgISRPHLLSFLYNMSSGTHLpesHDDHVKVLPVRAFRLEPyDNHGIITVDGERVEFGPLQ 647
Cdd:pfam19279  72 RIAPDARVDDGLLDVVVIEA-ASRRTLLRLLPKVYDGRHV---RLPQVEVLRGREVRIEA-DRPLPAGADGEVLGPLPVR 146
                          90
                  ....*....|..
gi 45550531   648 AEVLPGIARVMV 659
Cdd:pfam19279 147 VEVLPGALRVLA 158
PRK13055 PRK13055
putative lipid kinase; Reviewed
214-417 9.06e-05

putative lipid kinase; Reviewed


Pssm-ID: 237282 [Multi-domain]  Cd Length: 334  Bit Score: 44.98  E-value: 9.06e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  214 RRRVLVLLNPKSGsgdaREVFNMHVTPVLN---EAEVPYDLYVTKHSNFAIEFLSTRCLDA-WCCVVAVGGDGLFHEIVN 289
Cdd:PRK13055   2 QKRARLIYNPTSG----QEIMKKNVADILDileQAGYETSAFQTTPEPNSAKNEAKRAAEAgFDLIIAAGGDGTINEVVN 77
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  290 GLLQrqdwahvLPHLA-LGIIPCGSGNGLARSIAHCYNEPyfskpvLGAALTVISGRSSPMDVVRVQLQSrslYsFLSI- 367
Cdd:PRK13055  78 GIAP-------LEKRPkMAIIPAGTTNDYARALKIPRDNP------VEAAKVILKNQTIKMDIGRANEDK---Y-FINIa 140
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|..
gi 45550531  368 GWGLISDV--DIESERIRMLGYQRFTVWTLYRLVNLRTYNGRISYlltDHEV 417
Cdd:PRK13055 141 AGGSLTELtySVPSQLKSMFGYLAYLAKGAELLPRVSPVPVRITY---DEGV 189
PRK11914 PRK11914
diacylglycerol kinase; Reviewed
216-410 4.86e-03

diacylglycerol kinase; Reviewed


Pssm-ID: 237021 [Multi-domain]  Cd Length: 306  Bit Score: 39.38  E-value: 4.86e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  216 RVLVLLNPKSGSGDA-----REVFNMHVTPVLNEAEVPYDlyvTKHSNFAIEFLSTRCLDAwccVVAVGGDGLfheIVNG 290
Cdd:PRK11914  10 KVTVLTNPLSGHGAAphaaeRAIARLHHRGVDVVEIVGTD---AHDARHLVAAALAKGTDA---LVVVGGDGV---ISNA 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 45550531  291 LlqrQDWAHVlpHLALGIIPCGSGNGLARSiahcynepyFSKPV---LGAALTVISGRSSPMDVVRVQLQSRSLYSFLSI 367
Cdd:PRK11914  81 L---QVLAGT--DIPLGIIPAGTGNDHARE---------FGIPTgdpEAAADVIVDGWTETVDLGRIQDDDGIVKWFGTV 146
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|....*
gi 45550531  368 -GWGLISDVDIESERIRM-LGYQRFTVWTLYRLVNLRTYNGRISY 410
Cdd:PRK11914 147 aATGFDSLVTDRANRMRWpHGRMRYNLAMLAELSKLRPLPFRLVL 191
PRK13057 PRK13057
lipid kinase;
274-351 6.87e-03

lipid kinase;


Pssm-ID: 183857 [Multi-domain]  Cd Length: 287  Bit Score: 39.13  E-value: 6.87e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 45550531  274 CVVAVGGDGLFHEIVNGLLQRQdwahvlphLALGIIPCGSGNGLARSIahcyNEPyfskPVLGAALTVI-SGRSSPMDV 351
Cdd:PRK13057  53 LVIVGGGDGTLNAAAPALVETG--------LPLGILPLGTANDLARTL----GIP----LDLEAAARVIaTGQVRRIDL 115
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH